MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer

计划入组 27 人 · 首次发布于 2015 年 3 月 27 日

the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors

计划入组 27 人 · 首次发布于 2021 年 1 月 22 日

Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors

计划入组 28 人 · 首次发布于 2016 年 7 月 11 日

Anti-PD-L1 monoclonal antibody(Iontas)

anti-TAGE monoclonal antibody

Recombinant anti-PD-L1 human monoclonal antibody

Cambridge Antibody Technology

New Zealand

Latticon Antibody Therapeutics, Inc

United States

Novel Anti-Infective Technologies, LLC

Akston Launches First-in-Class Canine Cancer Immunotherapy Trial Using Novel Fc-Fusion Platform

Akston Biosciences and Purdue University Launch Immunotherapy Trial for Canine Bladder Cancer

CStone Strikes Oceania Deal with Arrotex for Anti-PD-L1 Antibody Sugemalimab